Elanco Animal Health ELAN
NYSE ELAN
$24.25 -0.25 (-1.04%)
At close: Aug 20, 2026 · 11:03 AM UTC

Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026)

Elanco Animal Health (ELAN) posted Other Non-Current Assets of $295.0 million for Q1 2026, down 2.96% sequentially from $304.0 million in Q4 2025, and down 5.45% YoY from $312.0 million in Q1 2025.

Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Elanco Animal Health has reported Other Non-Current Assets for 10 years, with the latest figure at $295.0 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 5.45% year-over-year to $295.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $295.0 million (down 5.45% YoY) and the FY2025 annual result came in at $304.0 million, down 2.25% from the prior year.
  • Other Non-Current Assets fell to $295.0 million in Q1 2026 per ELAN's latest filing, from $304.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $559.0 million in Q1 2022 and troughed at $295.0 million in Q1 2026.
  • A 5-year average of $355.1 million and a median of $341.0 million in 2023 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets soared 72.0% in 2022, then plunged 33.99% in 2023.
  • Over 5 years, Other Non-Current Assets stood at $378.0 million in 2022, then dropped by 9.79% to $341.0 million in 2023, then declined by 8.8% to $311.0 million in 2024, then retreated by 2.25% to $304.0 million in 2025, then declined by 2.96% to $295.0 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $295.0 million, $304.0 million, and $306.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - 56.35 Mn
2 Teva Pharmaceutical Industries 43.31 Bn 39.66 Bn 2.15 Bn 1.79 Bn
3 Zoetis 31.65 Bn 29.98 Bn 1.05 Bn 384.00 Mn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 503.80 Mn
5 United Therapeutics 22.18 Bn 19.52 Bn 683.80 Mn 239.50 Mn
6 Viatris 18.82 Bn 17.94 Bn 1.46 Bn 1.06 Bn
7 Neurocrine Biosciences 15.70 Bn 15.31 Bn 935.80 Mn 59.30 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 304.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - 13.00 Mn
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn 62.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 304.00 Mn
Mar 31, 2026 295.00 Mn
Dec 31, 2025 304.00 Mn
Sep 30, 2025 306.00 Mn
Jun 30, 2025 308.00 Mn
Mar 31, 2025 312.00 Mn
Dec 31, 2024 311.00 Mn
Sep 30, 2024 302.00 Mn
Jun 30, 2024 324.00 Mn
Mar 31, 2024 346.00 Mn
Dec 31, 2023 341.00 Mn
Sep 30, 2023 410.00 Mn
Jun 30, 2023 419.00 Mn
Mar 31, 2023 369.00 Mn
Dec 31, 2022 378.00 Mn
Sep 30, 2022 376.00 Mn
Jun 30, 2022 376.00 Mn
Mar 31, 2022 559.00 Mn
Dec 31, 2021 390.00 Mn
Sep 30, 2021 357.00 Mn